900120 — CXI Healthcare Technology Balance Sheet
0.000.00%
- KR₩17bn
- -KR₩183bn
- CNY376.93m
- 45
- 100
- 6
- 51
Annual balance sheet for CXI Healthcare Technology, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,263 | 148 | 341 | 522 | 840 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 67.4 | 206 | 174 | 145 | 142 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,359 | 362 | 518 | 670 | 983 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 713 | 1,783 | 1,650 | 1,522 | 1,373 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,132 | 2,201 | 2,220 | 2,298 | 2,541 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 49.7 | 72.4 | 45.3 | 15.4 | 13.5 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 48.9 | 72.8 | 45.9 | 18.6 | 14.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 2,083 | 2,128 | 2,174 | 2,279 | 2,527 |
Total Liabilities & Shareholders' Equity | 2,132 | 2,201 | 2,220 | 2,298 | 2,541 |
Total Common Shares Outstanding |